Abstract
The stage of disease at presentation remains the most important prognostic factor for colon cancer patients. Stage I disease carries an excellent prognosis of more than 95% 5-year survival rate, and surgical treatment alone is sufficient; adjuvant treatment is not indicated. In contrast, adjuvant treatment has repeatedly been shown to improve survival for Stage III disease. The role of adjuvant treatment for Stage II (node-negative) disease remains controversial. However, high risk stage II patients should be considered for adjuvant chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Beck, D.E., Roberts, P.L., Rombeau, J.L., Stamos, M.J., Wexner, S.D. (2009). Adjuvant Therapy for Colorectal Cancer. In: Wexner, S., Stamos, M., Rombeau, J., Roberts, P., Beck, D. (eds) The ASCRS Manual of Colon and Rectal Surgery. Springer, New York, NY. https://doi.org/10.1007/b12857_31
Download citation
DOI: https://doi.org/10.1007/b12857_31
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-73438-5
Online ISBN: 978-0-387-73440-8
eBook Packages: MedicineMedicine (R0)